Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Hemosol (HML.TO)

BUY
Almost at the commercial stage
BUY
Good concept. Could have competition down the road, but a good company.
WAIT
Will probably get approved. Not sure how commercially viable it is.
TOP PICK
Just got on NASDAQ. With exposure in US, just got some good financing. Should double
DON'T BUY
Stock price has just dropped. Still a venture company and they don't invest unless there is cash flow.
DON'T BUY
Recently got new financing. Good company. No revenues yet. Prefers buying this via MDS
BUY
Expects it to be the leader in blood substitutes.
BUY
In phase 3. Expects it to be successful. Good mngmnt. Volatile. Play it through MDS.
BUY
Going up. May be because of the new exposure to US on NASDAQ
BUY
Now moving because of increased exposure to the US market through their NASDQ listing
BUY
Likes this stock. Everything is in place for manufacturing so expects revenues to start. Volatile
BUY
Has an outstanding product. Long term should be good, but prefers to play this through MDS
TOP PICK
Had a rough time because of rumors on competition problems. Good company. Dramatically undervalued. Will go much higher when US investors see it
WATCH
Very attractive product. A lot of competition
BUY
Just got some major financing. A big step
Showing 61 to 75 of 78 entries